The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the sale of the falsified brand of Chloroquine Phosphate tablets. The fake product was discovered and purchased from an informal dispensary in Jos, Plateau State, Nigeria.
TLC screening conducted on the tablets revealed that the product contains No active pharmaceutical ingredient (API).
Further details of the product are as follows:
| Product Name | C-QUI (Chloroquine Phosphate) |
| Stated dose | 250mg |
| Stated manufacturer | Kline Health Laboratory LTD, 76, Bello Ayinde Street, opp Saw-Mill market, Owode, Ogun State |
| Batch / Lot | CQLL0030 |
| Mfg. date | 03/2021 |
| Exp date | 02/2024 |
| Packaging language | English |
| Identified in | Nigeria |
Though the falsified product was observed to carry NAFDAC registration number 04-8769, it should be noted that the product is not registered by NAFDAC and is not in the NAFDAC database of registered products.
This product may have been distributed to several parts of the country through legal and illegal channels and it is important to detect and remove it from circulation to prevent harm to patients. Consequently, NAFDAC has directed all state offices to conduct surveillance and mop up all violating batches of the product.
NAFDAC implores importers, distributors, retailers, and healthcare providers to always exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and administration or use of falsified or substandard medicinal products. All medicinal products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
Members of the public in possession of the above-mentioned product are advised to discontinue sale or use and submit stock to the nearest NAFDAC office.
If you have this substandard product, please DO NOT use it. If you, or someone you know, have used the product or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional.
Healthcare professionals and consumers are advised to report any suspicion of substandard and falsified medicines to the nearest NAFDAC office, on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of the medicinal product to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med-safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng
NAFDAC……..Customer-focused, Agency-minded!!!
Signed Management
